2025 ASCO Annual Meeting
May 30, 2025, 5:00:00 AM UTC
Summary
Regeneron will present 18 studies on oncology and hematology, including updates on Libtayo and linvoseltamab, from May 30 to June 3, 2025, in Chicago, IL.
Company
REGENERON PHARMACEUTICALS INC (REGN)NASDAQ — Healthcare: Manufacturing, Biotechnology: Pharmaceutical Preparations
www.regeneron.comSimilar Events
2025 ASCO Annual Meeting Presentation
Incyte will present multiple abstracts featuring new data from its oncology portfolio at the 2025 ASCO Annual Meeting in Chicago, showcasing advancements in cancer therapies.
conference talkLINKER-MM2 Trial Results Presentation
Regeneron will present results from the LINKER-MM2 trial on June 2, 2025, focusing on linvoseltamab combinations in relapsed/refractory multiple myeloma.
clinical readoutPfizer at ASCO 2025
Pfizer will present data on breakthrough cancer medicines at the ASCO Annual Meeting from May 30 to June 3, showcasing over 60 abstracts across various cancer types.
conference talkASCO Annual Meeting
The 2025 ASCO Annual Meeting will take place from May 30 to June 3, 2025, in Chicago, Illinois, featuring various oncology presentations.
other